Tel Aviv, Israel

Orna Bregman-Amitai

This inventor holds 15 USPTO granted patents. Top assignees: Samsung Electronics Co., Ltd., Zebra Medical Vision Ltd., Bsp Biological Signal Processing Ltd.. Active years: 2011-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Orna Bregman-Amitai. Retrieved from https://idiyas.com/inventor/orna-bregman-amitai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 80.0

Average Co-Inventor Count = 2.7

ph-index = 9

Forward Citations = 193(Granted Patents)


Company Filing History:


Years Active: 2011-2020

Loading Chart...
15 patents (USPTO):Explore Patents

Title: Inventor Spotlight - Orna Bregman-Amitai

Introduction: Orna Bregman-Amitai is a pioneering inventor based in Tel Aviv, Israel, known for her groundbreaking contributions to the field of technology and innovation.

Latest Patents: Orna Bregman-Amitai holds several patents in the areas of artificial intelligence, machine learning, and cybersecurity, showcasing her expertise in cutting-edge technologies.

Career Highlights: With a career spanning over two decades, Orna Bregman-Amitai has worked with leading tech companies and research institutions, playing a key role in developing innovative solutions that have reshaped the industry.

Collaborations: Throughout her career, Orna Bregman-Amitai has collaborated with top researchers, engineers, and developers, fostering a culture of innovation and excellence in all her projects.

Conclusion: Orna Bregman-Amitai's passion for pushing the boundaries of technology and her relentless pursuit of innovation make her a true trailblazer in the world of inventions. Her work continues to inspire and drive advancements in the tech industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…